Bridger Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-117,341
Closed -$3.67M 32
2023
Q4
$3.67M Buy
+117,341
New +$3.67M 1.41% 18